← Scroll for more →
Janux Therapeutics, Inc. (JANX)
Pharmaceutical Preparations
Latest Price
$17.47
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
15.22
P/B Ratio
1.15
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 11.19M | $171.0M | 18.32% | -- | 2026-06-30 |
| BlackRock, Inc. | 6.13M | $94.0M | 10.04% | +701.4K | 2026-06-30 |
| Prosight Management, LP | 3.80M | $58.0M | 6.23% | +254.5K | 2026-06-30 |
| State Street Corp | 3.00M | $46.0M | 4.92% | +540.9K | 2026-06-30 |
| FMR LLC | 2.41M | $37.0M | 3.95% | -122.9K | 2026-06-30 |
| Federated Hermes, Inc. | 2.35M | $36.0M | 3.85% | +2.30M | 2026-06-30 |
| Point72 Asset Management, L.P. | 1.99M | $30.0M | 3.26% | +837.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.86M | $28.0M | 3.04% | +46.0K | 2026-06-30 |
| TCG Crossover Management, LLC | 1.79M | $27.0M | 2.93% | -- | 2026-06-30 |
| Alyeska Investment Group, L.P. | 1.65M | $25.0M | 2.70% | +46.1K | 2026-06-30 |